DNA methylation and hormone receptor status in breast cancer

被引：0
|
作者：
Elizaveta V. Benevolenskaya
Abul B. M. M. K. Islam
Habibul Ahsan
Muhammad G. Kibriya
Farzana Jasmine
Ben Wolff
Umaima Al-Alem
Elizabeth Wiley
Andre Kajdacsy-Balla
Virgilia Macias
Garth H. Rauscher
机构：
[1] College of Medicine,Department of Biochemistry and Molecular Genetics
[2] University of Illinois at Chicago (UIC),Department of Genetic Engineering and Biotechnology
[3] University of Dhaka,Department of Health Sciences
[4] The University of Chicago,Division of Epidemiology and Biostatistics
[5] Loyola University,Department of Pathology
[6] School of Public Health,undefined
[7] University of Illinois at Chicago (UIC),undefined
[8] University of Illinois at Chicago,undefined
来源：
Clinical Epigenetics | 2016年 / 8卷
关键词：
DNA methylation; Breast cancer; ER/PR hormone receptor status;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] CYTOMORPHOLOGICAL GRADING AND HORMONE RECEPTOR STATUS IN BREAST-CANCER
    SCHENCK, U
    BURGER, G
    JUTTING, U
    EIERMANN, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (51-52) : 1949 - 1953
  • [22] Breast Cancer: Studying the Influence of Hormone Receptor Status on Survival
    Lichert, Frank
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (01)
  • [23] RASEF expression correlates with hormone receptor status in breast cancer
    Shibata, Masahiro
    Kanda, Mitsuro
    Shimizu, Dai
    Tanaka, Haruyoshi
    Umeda, Shinichi
    Miwa, Takashi
    Hayashi, Masamichi
    Inaishi, Takahiro
    Miyajima, Noriyuki
    Adachi, Yayoi
    Takano, Yuko
    Nakanishi, Kenichi
    Takeuchi, Dai
    Noda, Sumiyo
    Kodera, Yasuhiro
    Kikumori, Toyone
    ONCOLOGY LETTERS, 2018, 16 (06) : 7223 - 7230
  • [24] SSRI use and breast cancer risk by hormone receptor status
    Patricia F. Coogan
    Brian L. Strom
    Lynn Rosenberg
    Breast Cancer Research and Treatment, 2008, 109 : 527 - 531
  • [25] Hormone exposure and estrogen receptor status at breast cancer diagnosis
    Bessonova, Leona
    Ziogas, Argyrios
    Largent, Joan
    Anton-Cuiver, Hoda
    CANCER RESEARCH, 2009, 69
  • [26] Assessment of DNA methylation status in early stages of breast cancer development
    van Hoesel, A. Q.
    Sato, Y.
    Elashoff, D. A.
    Turner, R. R.
    Giuliano, A. E.
    Shamonki, J. M.
    Kuppen, P. J. K.
    van de Velde, C. J. H.
    Hoon, D. S. B.
    BRITISH JOURNAL OF CANCER, 2013, 108 (10) : 2033 - 2038
  • [27] Assessment of DNA methylation status in early stages of breast cancer development
    A Q van Hoesel
    Y Sato
    D A Elashoff
    R R Turner
    A E Giuliano
    J M Shamonki
    P J K Kuppen
    C J H van de Velde
    D S B Hoon
    British Journal of Cancer, 2013, 108 : 2033 - 2038
  • [28] DNA methylation in breast cancers: Differences based on estrogen receptor status and recurrence
    Williams, Kristin E.
    Jawale, Rahul M.
    Schneider, Sallie S.
    Otis, Christopher N.
    Pentecost, Brian T.
    Arcaro, Kathleen F.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (01) : 738 - 755
  • [29] DNA methylation and breast cancer
    Szyf, M
    Pakneshan, P
    Rabbani, SA
    BIOCHEMICAL PHARMACOLOGY, 2004, 68 (06) : 1187 - 1197
  • [30] DNA methylation in breast cancer
    Yang, X
    Yan, L
    Davidson, NE
    ENDOCRINE-RELATED CANCER, 2001, 8 (02) : 115 - 127
12345